Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
NF-κB–YAP Control of Pyroptosis in Ulcerative Colitis
2026-09-23
A 2026 study links NF-κB p65 activation to LATS1-associated YAP inactivation and increased NLRP3 expression, connecting inflammatory signaling with pyroptosis in ulcerative colitis models. Its cell and mouse experiments suggest that YAP can restrain epithelial pyroptosis, while GSDMD-dependent cell death contributes to colitis severity.
-
A40926 Production Tools in Nonomuraea
2026-09-23
Yushchuk and colleagues developed promoter-reporter tools for genetically recalcitrant Nonomuraea species and used them to identify regulatory strategies for improving A40926 biosynthesis. Overexpression of pathway-specific positive regulators increased production, providing a knowledge-based route to strain improvement and a foundation for future glycopeptide engineering.
-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-09-22
The reference study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1, rather than stabilizing or folding the enzyme. These findings establish mitochondrial proteostasis as a post-translational regulator of TCA-cycle activity and carbohydrate catabolism, with implications for interpreting metabolic phenotypes in cells and mice.
-
Ertugliflozin Beyond Glucose: A Translational Playbook
2026-09-22
Ertugliflozin (PF-04971729) illustrates why target selectivity is only the starting point for translational research. This thought-leadership guide connects renal glucose transport, comparative cardioprotection, assay design, and ulcerative colitis research into a practical framework for interpreting mechanism, exposure, and disease-context effects.
-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-09-21
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work expands the role of mitochondrial proteostasis from protein folding to targeted control of a rate-limiting metabolic enzyme, with consequences for OGDH complex activity and carbohydrate catabolism.
-
HOBt in Route Design: From Coupling to SAR
2026-09-21
HOBt (1-Hydroxybenzotriazole) is more than a peptide-coupling additive: it can shape stereochemical control and route reliability in medicinal chemistry. This article examines its mechanism through an indazole glucagon receptor antagonist synthesis and translates the evidence into practical workflow decisions.
-
Bestatin as a Chemical Probe of Jasmonate Signaling
2026-09-20
The reference study established bestatin as a chemical-genetic probe for jasmonic acid signaling in Arabidopsis and tomato, rather than merely an aminopeptidase inhibitor. By combining gene-expression analysis, pathway mutants, developmental phenotyping, and resistant-mutant screening, the authors identified distinct genetic classes that help separate jasmonate perception, response, and bestatin-specific effects.
-
Tetracycline C6589 for Reliable Cell Assays
2026-09-19
Learn how Tetracycline (SKU C6589) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing antibiotic selection effects with biological endpoints. This scenario-based guide covers mechanism, assay controls, DMSO preparation, interpretation, and evidence-based product selection.
-
PTX3–TLR4/NF-κB–FGF21 Axis in Glucocorticoid ONFH
2026-09-18
The reference study identifies PTX3 as a protective regulator of glucocorticoid-induced osteonecrosis of the femoral head and places it upstream of a TLR4/NF-κB/FGF21 signaling axis. Its combination of patient samples, cellular models, knockout mice, recombinant protein rescue, and pathway blockade provides a mechanistic framework for studying impaired osteogenesis and apoptosis in ONFH.
-
Mifepristone (RU486) Experimental Workflows
2026-09-18
Mifepristone (RU486) provides a practical pharmacological switch for testing progesterone receptor-dependent biology in cancer and reproductive models. This guide combines dose planning, receptor-context controls, quantitative readouts, and troubleshooting strategies for more interpretable experiments.
-
Methyl-β-cyclodextrin Protocol and QC Guide
2026-09-17
Methyl-β-cyclodextrin (SKU C6939) is a 98.00% reagent for controlled membrane cholesterol extraction and studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It is intended for scientific research only; concentration, exposure time, vehicle, and cell-model compatibility must be established empirically, and prepared solutions should not be stored long term.
-
Human Sensory Neurons Model HSV-1 Latency
2026-09-17
Oh et al. developed a scalable human iPSC-derived sensory neuron system that reproduces major molecular and functional features of HSV-1 latency and supports chemically induced reactivation. The model provides a human-relevant platform for studying neuron-intrinsic latency mechanisms while clarifying the limitations of extrapolating from animal systems.
-
Liproxstatin-1 HCl: Assay Logic
2026-09-16
Liproxstatin-1 HCl is examined here as a causal assay tool for separating ferroptosis from broader oxidative or apoptotic injury. The article connects its rescue phenotype with the mitochondrial calcium–GPX4 axis and explains how to interpret cellular and organ-injury results without overstating translational maturity.
-
Dacarbazine in Translational Oncology
2026-09-16
A mechanistic and strategic framework for using Dacarbazine as a translational benchmark across DNA damage, experimental validation, competitive benchmarking, supportive care, and clinical research.
-
MK-1775: Wee1 Kinase Inhibitor Workflows
2026-09-15
Build more informative MK-1775 experiments by separating growth arrest from cell killing, then pair Wee1 inhibition with DNA-damaging treatment in genetically defined models. This guide combines checkpoint pharmacology, time-resolved assay design, and troubleshooting for reproducible cancer research workflows.